Try our corporate solution for free!
(212) 419-8286

Brazil: net revenue of Hypera Pharma 2012-2019

Hypera Pharma is a Brazilian pharmaceutical company headquartered in São Paulo, and formerly named Hypermarcas. The company reported a net revenue of approximately 3.3 billion Brazilian reals in 2019, a decrease of 11.6 percent in comparison to the previous year.

Net revenue of Hypera Pharma in Brazil from 2012 to 2019

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

$39 $59 per month *
in the first 12 months
33% discount until May 31st
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in

Release date

October 2020


Brazil, Central and South America

Survey time period

2012 to 2019

Special properties

data based on the company's financial statements

Supplementary notes

Figures preceding 2019 were taken from the source's earlier releases.
In December 2017, the company changed its denomination from Hypermarcas to Hypera Pharma.
Numbers have been rounded.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical industry in Brazil"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.